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Abstract 
Objective 
To identify an evidence-based minimum physical activity threshold to predict improved or sustained 
high function for adults with lower-extremity joint symptoms. 
Methods 
Prospective multisite data from 1,629 adults, age ≥49 years with symptomatic lower‐extremity joint 
pain/aching/stiffness, participating in the Osteoarthritis Initiative accelerometer monitoring substudy 
were clinically assessed 2 years apart. Improved/high function in 2-year gait speed and patient-reported 
outcomes (PROs) were based on improving or remaining in the best (i.e., maintaining high) function 
quintile compared to baseline status. Optimal thresholds predicting improved/high function were 
investigated using classification trees for the legacy federal guideline metric requiring 150 minutes/week 
of moderate-vigorous (MV) activity in bouts lasting 10 minutes or more (MV-bout) and other metrics 
(total MV, sedentary, light intensity activity, nonsedentary minutes/week). 
Results 
Optimal thresholds based on total MV minutes/week predicted improved/high function outcomes more 
strongly than the legacy or other investigated metrics. Meeting the 45 total MV minutes/week threshold 
had increased relative risk (RR) for improved/high function (gait speed RR 1.8, 95% confidence interval 
[95% CI] 1.6, 2.1 and PRO physical function RR 1.4, 95% CI 1.3, 1.6) compared to less active adults. 
Thresholds were consistent across sex, body mass index, knee osteoarthritis status, and age. 
Conclusion 
These results supported a physical activity minimum threshold of 45 total MV minutes/week to promote 
improved or sustained high function for adults with lower-extremity joint symptoms. This evidence-
based threshold is less rigorous than federal guidelines (≥150 MV‐bout minutes/week) and provides an 
intermediate goal towards the federal guideline for adults with lower-extremity symptoms. 
INTRODUCTION 
Physical activity is endorsed as a healthy lifestyle strategy. Federal guidelines for adults stipulate a 
minimum threshold of 150 minutes/week of moderate intensity, or 75 minutes of vigorous-intensity 
physical activity or an equivalent combination.1 These guidelines utilize a legacy metric requiring activity 
bouts of moderate or vigorous activity lasting at least 10 minutes, based on studies demonstrating 
cardiovascular benefits from aerobic activity.2-5 However, the vast majority of adults fail to meet these 
guidelines.6,7 Even more concerning is that as many as 2 in 5 adults with lower-extremity joint conditions 
not only fail to meet guidelines, they register zero on the legacy bout metric; over an entire week they 
do not have a single session of moderate physical activity lasting 10 minutes.8,9 
Box 1. Significance & Innovations  
• These results support an intermediate threshold to spend at least 45 minutes/week in 
accumulated physical activity of at least moderate intensity among adults having lower‐
extremity joint symptoms. 
• This evidence‐based threshold is less rigorous than federal guidelines (150 minutes/week of 
moderate to vigorous activity in bouts lasting 10 minutes or more). 
Maintaining function is crucial to independent community living for adults with physical impairments. 
For many adults living with joint conditions, improving or maintaining high function may be as great a 
concern as cardiovascular health. Physical function has long been recognized as a proxy for overall 
health. Physical function assessed by gait speed reflects functional status and health.10 Gait speed has 
been repeatedly associated with survival in epidemiologic studies.11-13 Similarly, patient‐reported 
functional status is related to quality of life and life expectancy.14 Lower‐extremity joint conditions such 
as hip or knee osteoarthritis (OA) increase a person's risk for subsequent loss of function.12,15 While 
being physically active is associated with functional gains16 among adults with joint disease.17 it is not 
known if there is a level of physical activity that may promote better function or maintain high 
functional ability.18  
Investigating what physical activity levels might improve low function or maintain high (improved/high) 
function among adults with lower‐extremity symptoms motivates 2 questions: 1) Are there alternative 
physical activity metrics that better predict improved/high function than the legacy bout–based metric, 
which registers zero for a large portion of these adults? and 2) What minimum threshold of physical 
activity best predicts improved/high function? The objective of this study is to identify optimal physical 
activity metrics and dosage thresholds related to improving low function or maintaining high function 
among adults with lower‐extremity joint symptoms. 
MATERIALS AND METHODS 
Study population 
Participants were a subcohort of the Osteoarthritis Initiative (OAI) enrolled into an accelerometer 
ancillary study conducted at the OAI 2008–2010 clinic visit (OAI 4‐year followup), which is baseline for 
this study. The OAI is a multicenter prospective study investigating risk factors and biomarkers for the 
progression and/or onset of knee OA (see http://www.oai.ucsf.edu/datarelease/About.asp). At 
enrollment, the OAI recruited 4,796 men and women between ages 45 and 79 years from 4 clinical sites: 
Baltimore, Maryland; Pittsburg, Pennsylvania; Pawtucket, Rhode Island; and Columbus, Ohio. The OAI 
enrolled participants with or at high risk for developing symptomatic, radiographic knee OA. High risk 
was defined as frequent knee symptoms without radiographic OA, or 2 or more eligibility risk factors 
(e.g., age, high body mass index [BMI], prior knee injury, knee surgery, family history of total knee 
replacement for OA, Heberden's nodes, and repetitive knee bending).19 OAI eligibility criteria have been 
described in detail elsewhere.20 Approval was obtained from the institutional review board at each OAI 
site and at Northwestern University. Each participant provided written informed consent.  
A subgroup of 2,127 OAI participants participated in an accelerometer study at the 48‐month clinic visit, 
which represents our study's baseline. Eligibility for the substudy required a scheduled OAI followup visit 
between August 2008 and June 2010. The present study sample included 1,919 accelerometer study 
participants reporting ankle, foot, knee, and/or hip lower‐extremity joint symptoms of pain, aching, or 
stiffness. Ankle, foot, and knee questions solicited symptoms over the past 30 days; hip questions 
solicited symptoms over the past 12 months. Of individuals reporting hip symptoms, 90% were in the 
analysis sample based on symptoms reported in another joint. Loss to followup was minimal; over 96% 
of this cohort (1,845 of 1,919) participated in a followup visit 2 years later. For analysis purposes, we 
restricted our sample to 1,647 individuals with baseline and 2‐year followup (2010–2012) physical 
function measured objectively by gait speed (n = 1,476) and/or by patient‐reported outcome (PRO) 
based on the 12‐item Short Form (SF‐12) health survey physical component score (n = 1,629), 
respectively (Figure 1). Excluded were 173 persons with inadequate accelerometer monitoring to 
support reliable physical activity estimates 7 (i.e., less than 4 valid days of monitoring based on daily 
evidence of ≥10 hours of accelerometer wear), and 89 participants did not have 2‐year followup 
outcomes (64 with no contact, 23 with only phone contact, and 2 refused).  
 
Figure 1. Flow of analytical sample. * = participants with scheduled visits outside the substudy recruitment period; 
SF‐12 = 12‐item Short Form health survey; PCS = physical component score. 
Outcomes 
The primary outcome was change in improved or high (improved/high) physical function status between 
baseline and 2-year followup, separately assessed by objective gait speed and by the PRO physical 
function SF-12 physical component score. Improved/high function was based on transitions across 
functional quintiles over time. This method captures practical, meaningful changes in function over time 
in OA populations.21-23 Five quintile groups are defined from the full parent enrollment OAI knee OA 
cohort for objective gait speed physical function (Q1: <3.7, Q2: 3.7–4.0, Q3: 4.1–4.3, Q4: 4.4–4.7, and 
Q5: ≥4.8 feet per second) and PRO physical function (Q1: <39.4, Q2: 39.4–46.9, Q3: 47.0–52.1, Q4: 52.2–
56.0, and Q5: ≥56.1). Baseline and 2‐year function scores from accelerometer substudy participants 
(n = 1,647) were categorized into each of these groups. Subsequent improved/high function was defined 
by maintaining function in the best group (i.e., Q5 at both evaluations) or moving into a better group 
(i.e., moving from Q1–Q4 to a higher group) at 24 months compared to baseline. We used function 
transitions to identify improved/high physical function outcomes rather than an improvement exceeding 
a minimum clinically important difference (MCID) due to 1) the value of retaining participants who 
maintain high function (e.g., participants whose high baseline function makes them unable to improve 
an MCID) and 2) validity concerns when applying MCIDs estimated from randomized clinical trial 
samples to community populations.24 
Physical activity assessment 
Physical activity was monitored using the ActiGraph GT1M uniaxial accelerometer.25 Trained research 
personnel gave uniform scripted in‐person instructions to wear the accelerometer for 7 consecutive 
days on a belt at the natural waistline in line with the right axilla upon arising in the morning until 
retiring, except during water activities. Participants maintained a daily log to record time spent in water 
and cycling activities, which may not be fully captured by accelerometers. Such activity was negligible 
(interquartile range [IQR] 0–0 minutes/week) and not utilized in the present study.  
Accelerometer data were analytically filtered using validated methodology.26,27 Nonwear periods were 
defined as ≥90 minutes with zero activity counts (allowing for 2 consecutive interrupted minutes with 
counts <100).7 We identified participants with 4–7 valid monitoring days (i.e., ≥10 wear hours per day) 
needed for reliable physical activity estimates.7 Thresholds used by the National Cancer Institute on a 
minute‐by‐minute basis were applied to identify intensity levels as sedentary (counts/minute <100), 
nonsedentary (counts/minute ≥100), light (100–2,019 counts/minute), and moderate‐to‐vigorous (MV; 
counts/minute ≥2,020) (MV‐total),7 and MV activity accumulated in bouts lasting ≥10 minutes (MV‐
bout). Due to negligible vigorous (counts/minute ≥5,999) activity (median 0, IQR 0–0 minutes/week) in 
this cohort, vigorous time and vigorous bouts were not separately evaluated. Weekly activity minutes 
spent at each intensity level are summed from the daily totals over the monitoring hours and averaged 
across valid monitored days; for individuals with 4, 5, or 6 valid days of monitoring, weekly activity 
minutes were estimated as 7 average daily activity minutes spent at each intensity level.  
Baseline covariates 
Demographic factors included age and sex. BMI was calculated from measured height and weight 
(kg/m2) to classify individuals as normal weight (BMI 18.5–24.9), overweight (BMI 25.0–29.9), or obese 
(BMI ≥30). If baseline (i.e., OAI 4‐year) BMI was missing (0.2%, n = 4), the most recent annual assessment 
was used as a proxy. Knee OA was identified by a Kellgren/Lawrence grade of ≥2 in 1 or both knees 
assessed from fixed-flexion knee radiography protocol.28 
Statistical analysis 
Candidate metrics (sedentary, nonsedentary, light, and MV‐total) were screened by comparing each to 
the legacy MV‐bout metric, the basis for assessing current physical activity guidelines. For this purpose, 
we calculated the area under the receiver operating characteristic curve (AUC) to transform the 
predictive ability of each metric to a common 0 to 1 scale. For each legacy and candidate metric we first 
derived the receiver operating curve, which is graphically represented by the metric sensitivity plotted 
versus the fraction of false positives (i.e., 1‐specificity) in relation to a physical function outcome. We 
then determined the AUC area.29 Candidate metrics that performed at least as well (i.e., greater than 
the AUC) as the legacy MV‐bout reference metric AUC were retained for predictive modeling. 
Comparison of candidate metric AUC with the legacy MV‐bout AUC used a test developed by Delong et 
al.30  
Thresholds were identified using classification and regression tree (CART) methodology. We separately 
predicted improved/high gait speed and improved/high PRO physical function. For both outcomes, all 
candidate metrics with AUCs that exceeded the reference MV‐bout metric AUC were used as 
classification tree predictors in addition to the reference MV‐bout metric. A classification tree identifies 
the predictors and threshold of the selected predictor with the strongest relationship to the outcome 
based on the criterion of minimum classification error.31 To avoid overfitting, models were evaluated 
using cross‐validation subsets and pruned to the most parsimonious model within 1 standard prediction 
error from the best‐fit model.32 Classification tree analysis was selected over other traditional methods 
(e.g., stepwise logistic regression), given the goal to identify thresholds in an optimal prediction model 
(i.e., minimize misclassification error).33,34 Analyses were performed using Salford Predictive Modeler 
software, version 8.0.35 Classification tree algorithms retain all records having outcomes; missing 
predictors are handled by substituting “surrogate splitters,” which are back‐up rules that closely mimic 
the primary splitting rules. Recognizing that systematic differences between people with and without 
followup outcomes could influence our findings, we conducted weighted analyses recommended by 
Hogan et al.36 For simplicity, we report unweighted analyses because weighted analyses provided 
identical findings. To investigate the stability of thresholds across age, sex, BMI, and radiographic knee 
OA presence, we performed sensitivity analyses. Each factor was separately entered into a classification 
tree analysis in addition to physical activity metrics to predict improved/high function to explore 
separate thresholds within the factor investigated. Other analyses were performed using SAS software, 
version 9.4. Statistical testing was conducted at a 2‐sided 5% significance level.  
RESULTS 
Participants in the OAI accelerometer substudy with baseline lower‐extremity joint symptoms and 
subsequent function outcomes (n = 1,647) were primarily female (56%), obese (37%), and ranged in age 
from 49 to 83 years. The most common lower‐extremity symptoms reported were knee symptoms 
(93%, 61% of these had radiographic disease), followed by hip symptoms (60%), foot symptoms (12%), 
and ankle symptoms (11%). Both hip and knee symptoms were reported by 54% of this sample. 
The baseline values of the legacy physical activity metric and candidate metrics are shown in Table 1 by 
subsequent improved/high function status. At the 2‐year followup, 34% (500 of 1,476) had 
improved/high gait speed and 38% (622 of 1,629) had improved/high PRO physical function. The 
baseline legacy MV‐bout metric and MV‐total activity metric showed the greatest separation across all 
metrics between people who did or did not belong to improved/high function groups (25% difference or 
greater). It is notable that only sedentary time did not significantly differ between groups for either 
function measure.  
Table 1. Baseline physical activity metrics of adults by physical function status at 2-year followupa 
 Improved/high objective gait speed 
(n = 1,476) Improved/high PRO (n = 1,629) 
Baseline physical activity 
metric, minutes/week 
Yes 
(n = 500) 
No 
(n = 976) 
Difference 
(95% CI) 
Yes 
(n = 622) 
No 
(n = 1,007) 
Difference 
(95% CI) 
Legacy metric MV‐boutb 76 ± 111 47 ± 87 29 (19, 40) 68 ± 103 50 ± 92 17 (8, 27) 
Candidate metrics       
 Improved/high objective gait speed 
(n = 1,476) Improved/high PRO (n = 1,629) 
Baseline physical activity 
metric, minutes/week 
Yes 
(n = 500) 
No 
(n = 976) 
Difference 
(95% CI) 
Yes 
(n = 622) 
No 
(n = 1,007) 
Difference 
(95% CI) 
Sedentary 4,123 ± 647 4,118 ± 614 5 (−63, 72) 4,125 ± 629 4,122 ± 620 3 (−59, 66) 
Light activity 2,058 ± 536 1,964 ± 554 94 (36, 154) 2,002 ± 524 1,964 ± 558 38 (−17, 93) 
MV‐totalc 166 ± 149 108 ± 122 58 (43, 72) 146 ± 141 114 ± 129 33 (19, 46) 
Nonsedentary 2,224 ± 576 2,072 ± 599 152 (89, 216) 2,149 ± 568 2,078 ± 605 71 (12, 130) 
a Values are the mean ± SD unless indicated otherwise. PRO = patient‐reported outcome; 95% CI = 95% 
confidence interval; MV = moderate to vigorous activity.  
b Minutes of MV physical activity acquired in bouts lasting 10 or more minutes.  
c Total accumulated minutes of MV physical activity.  
 
The relative predictive value of each metric to distinguish improved/high function status at 2 years is 
visually represented by receiver operating characteristic curves shown in Figure 2A for improved/high 
gait speed function and Figure 2B for improved/high PRO physical function. The calculated AUC indicates 
all metrics performed better than a random “coin flip” (AUC 0.5) to predict improved/high function 
measures. However, only the MV-total activity metric had greater AUC than the legacy MV-bout 
reference metric to predict both improved/high gait speed (AUC 0.65 versus 0.60; difference 0.05; 95% 
CI 0.03, 0.07) and PRO physical function (AUC 0.59 versus 0.57; difference 0.02; 95% CI 0.001, 0.03). 
 Figure 2 Receiver operating characteristic (ROC) curves for improved/high physical function outcomes for A, 
objective gait speed and B, patient‐reported outcomes at 2 years by physical activity metrics. MV = moderate to 
vigorous physical activity. 
Classification tree analysis was used to identify both the optimal metric and the physical activity 
threshold to best predict improved/high function. The MV-total candidate metric and the reference MV-
bout metric were entered as classification tree predictors. Separate trees were grown to predict 
improved/high gait speed and improved/high PRO physical function outcomes. The optimal classification 
trees are shown in Figure 3. The MV-total metric was selected over MV-bout as the best predictor of 
both outcomes, consistent with the Figure 2 AUC analyses. The optimal threshold to predict 
improved/high objective gait speed physical function was 45 MV-total minutes/week. The optimal 
minimum threshold to predict improved/high PRO physical function was 47 MV-total minutes per week. 
 Figure 3 Classification trees selecting physical activity dosage thresholds to predict improved/high 2-year function 
in A, objective gait speed physical function and B, patient-reported physical function. MV = moderate to vigorous 
physical activity. 
Sensitivity analyses investigated whether optimal physical activity thresholds were specific to age, sex, 
presence/absence of knee OA, or BMI. Each factor was separately entered in addition to MV‐total and 
MV‐bout into a classification tree analysis to predict improved/high function in gait speed and in PRO 
physical function. Seven of the 8 sensitivity classification tree analyses (i.e., 4 exposure factors × 2 
outcome trees) solely selected an MV‐total threshold (MV‐total thresholds of 45 minutes/week for gait 
speed and 47 minutes/week for PRO physical function). One of the 8 sensitivity analyses to predict 
improved/high gait speed initially split on age (age ≤69 years MV‐total threshold: 46 minutes/week, age 
>69 years threshold: none). Further investigation of the age >69 years subgroup identified a candidate 
MV‐total threshold (10 minutes/week), but the improvement in prediction accuracy was insufficient for 
retention (i.e., below the 1 SE rule criterion). These sensitivity analyses demonstrate good stability of 
the MV‐total thresholds. 
Table 2 summarizes the ability of the thresholds to predict subsequent improved/high function based on 
relative risks (RRs). The optimal gait speed MV‐total threshold (>45 minutes/week) better discriminated 
subsequent improved/high function status than the current guideline (MV‐bout ≥150 minutes/week) 
demonstrated by the stronger RR (1.8 versus 1.4). Similarly, the optimal PRO physical function MV‐total 
threshold (>47 minutes/week) had a higher RR (1.4 versus 1.3) to predict improved/high function than 
the current guideline.  
Table 2. Improved/high 2‐year function relative risk for physical activity metrics by dosage thresholds 
among adults with baseline lower‐extremity symptomsa 
Physical activity, 
minutes/week 
Improved/high objective gait speed 
(n = 1,476) 
Improved/high PRO 
(n = 1,629) 
Legacy threshold   
Physical activity, 
minutes/week 
Improved/high objective gait speed 
(n = 1,476) 
Improved/high PRO 
(n = 1,629) 
 MV‐bout ≥150b 1.4 (1.3, 1.6) 1.3 (1.2, 1.4) 
Optimal threshold   
 MV‐total ≥45c 1.8 (1.6, 2.1) 1.4 (1.3, 1.6) 
 MV‐total ≥47d 1.8 (1.6, 2.0) 1.4 (1.3, 1.6) 
a Values are the relative risk (95% confidence interval). PRO = patient‐reported outcome; 
MV = moderate to vigorous activity.  
b Minutes of MV physical activity acquired in bouts lasting 10 or more minutes.  
c Total minutes of MV physical activity. Optimal threshold for improved/high gait speed function.  
d Total minutes of MV physical activity. Optimal threshold for improved/high PRO physical function 
based on the Short Form 12‐item medical survey physical component score.  
 
Recognizing that a common threshold has communication advantages for public health applications, we 
further investigated the predictive ability of both MV-total thresholds for each functional outcome. 
Specifically, we evaluated if evidence supported a conceptually easier 45 minutes/week target for a 
common MV-total threshold. Table 2 illustrates the threshold predictive ability of MV-total >45 
minutes/week compared to MV-total >47 minutes/week to distinguish improved/high gait speed as 
identical (RR 1.8 versus 1.8) or PRO physical function (RR 1.4 versus 1.4). The similar performance across 
the functional outcomes tested supports a common MV-total >45-minute threshold to predict 
subsequent improved/high function. 
DISCUSSION 
The primary finding from this longitudinal study of adults with lower‐extremity joint symptoms 
(n = 1,647) supports a minimum threshold of 45 minutes/week physical activity of MV‐total activity to 
improve low function or sustain high function over 2 years. Attaining this evidence‐based threshold 
better predicted improved/high function in gait speed and PRO physical function than the current 
federal physical activity threshold and represents a less stringent standard than current guidelines (i.e., 
MV‐bout ≥150 minutes/week). For adults with lower‐extremity joint symptoms who often do little or no 
moderate activity, a less demanding physical activity target tied to function may be a valuable 
intermediate benchmark towards meeting the current physical activity guideline. 
To our knowledge, this is the first study to investigate aerobic physical activity thresholds related to 
functional outcomes for adults living with lower‐extremity joint symptoms. Evidence supporting the 
World Health Organization and US physical activity guidelines for adults was initially based on consensus 
of evidence for cardiovascular benefits related to the 150 MV‐bout minute/week threshold.37 An 
extensive literature now supports broad morbidity and mortality benefits of meeting this guideline. A 
systematic literature review concluded that engaging in recommended levels of physical activity could 
reduce the risk of developing cardiovascular disease, stroke, hypertension, colon and breast cancer, type 
2 diabetes mellitus, and osteoporosis based on the most methodologically sound studies.38 Moreover, 
guideline adherence could result in 20% or greater reduced risk for premature all‐cause mortality among 
adults with chronic disease.38-40 Despite strong evidence for meeting current physical activity guidelines 
to support cardiovascular health and a wide range of potential health benefits for the general adult 
population, many adults with mobility‐limiting conditions fail to achieve this goal. Fewer than 11% of US 
adults with knee OA achieve current physical activity guidelines.41 This problem motivates investigating 
potential intermediate thresholds related to different health benefits, in order to encourage adults with 
lower‐joint symptoms to pursue physical activity.  
Being physically active can improve function and reduce joint symptoms among adults with lower‐
extremity conditions. Randomized clinical trials demonstrate the benefit of physical activity programs to 
improve physical function in adults with lower‐extremity conditions, including hip and knee OA.42-45 
Nonstructured moderate activity, such as walking, can improve function and reduce symptomatic pain, 
fatigue, and stiffness among adults with rheumatic disease.46,47  
Longitudinal studies support a dose‐response relationship between physical activity and function. A 
systematic review of the long‐term effect of physical activity among older adults having knee pain found 
no evidence of worsened symptoms related to pain, loss of physical function, or progression in 
structural disease.48 One case–control study concluded that increasing levels of regular physical activity 
was associated with a lower risk of disease progression to total knee replacement.49 Adults with 
mobility‐limiting conditions such as knee OA who achieved current physical activity guidelines by 
engaging in low‐impact physical activity experienced substantial improvement in physical function, pain, 
and quality of life. Although the benefits from physical activity to improve function are recognized, the 
minimum time commitment needed to experience health benefits is not known.50  
Physical activity decreases with older age. Physical activity studies of adults based on objective 
accelerometer monitoring indicate only 10–15% of community‐dwelling adults meet national guidelines, 
even after adjusting for age‐related decline in physical activity capacity.6,51 This reality, combined with a 
dose‐response relationship between physical activity and health, motivates clinical advice not to 
abandon guidelines, but to encourage older adults to pursue achievable incremental increases in 
physical activity.52 People who endure symptomatic joint disease often have a more difficult time being 
physically active than the general population and are at elevated risk for functional loss.52,53 Needed for 
this large population group is evidence to specify the amount and the intensity of physical activity 
associated with good functional outcomes.  
Our study directly addressed the need for an evidence‐based threshold for adults with lower‐extremity 
symptoms by identifying physical activity metrics and thresholds that best predicted improved function 
or maintenance of high functional ability over a 2‐year period. A big data approach using classification 
prediction trees identified that a minimum threshold of 45 total minutes of physical activity of at least 
moderate intensity acquired over 1 week predicted improved/high function in both objectively 
measured and PRO physical function. Sensitivity analyses indicated these MV‐total thresholds were 
stable independent of sex, BMI, the presence of knee OA, and age. This evidence‐based threshold 
predicting good functional outcomes is different from the current guideline in 2 ways. First, the selected 
MV‐total metric captured all weekly time spent in activities of at least moderate intensity, as opposed to 
the legacy metric that included only MV activity time acquired in bouts lasting at least 10 minutes. For 
people with lower‐extremity symptoms, the removal of the 10‐minute bout constraint is a realistic step 
forward to increase activity levels in a symptomatic population, because those symptoms can inhibit 
deconditioned people (like those with joint issues) from being able to sustain 10 minutes of MV physical 
activity. Second, the evidence‐based threshold requires a lower physical activity dose (i.e., fewer weekly 
minutes of MV activity) than current guidelines. The identified evidence‐based MV‐total >45 
minutes/week threshold related to improved/high function is less stringent than the current aerobic 
guideline, but does not replace the current guideline, which supports many other health benefits. 
Strengths of the study included prospective data collection across multiple sites, the large sample size, 
the objective assessment of physical activity, and the age and sex diversity of this cohort. Study 
limitations need to be considered in interpreting results. The OAI sample does not represent the general 
population. The present sample was composed of adults with lower‐extremity joint symptoms from a 
cohort having or at high risk for developing knee OA. This sample may include a larger proportion of 
adults with symptomatic knees than the general population with lower‐extremity symptoms, which may 
influence the generalizability of these results. However, the intentional stratified OAI recruitment 
produced a diverse cohort across age and sex. Although the OAI ascertainment of hip symptoms used a 
longer time frame than foot, ankle, or knee symptom ascertainment, 90% of people reporting hip 
symptoms would be in the sample solely due to their additional report of other lower‐extremity joints. It 
is notable that physical activity thresholds held within subgroups, with and without radiographic 
evidence of knee OA, support the robustness of these findings to disease status. Although an important 
methodologic strength is the objective measurement of physical activity using accelerometers, it is 
recognized the accelerometers used cannot capture water activities and may underestimate activities 
with minimal vertical acceleration/deceleration, such as cycling. However, time spent in these activities 
was negligible. It is acknowledged that other outcome definitions may yield different thresholds, and 
unreported treatments or factors may influence outcomes. Causation cannot be inferred from these 
observational data. Further research is warranted to confirm these findings 
The current study supports an intermediate threshold to spend at least 45 minutes/week in 
accumulated physical activity of at least moderate intensity among adults having lower‐extremity joint 
symptoms. This threshold to support improved/high function represents a less demanding goal than 
current federal physical activity guidelines in 2 ways. First, all time spent in MV activities contributes to 
attaining this function‐related minimum threshold, in contrast to the current MV‐bout threshold, which 
is only met through activity acquired in bouts lasting at least 10 minutes. Second, a minimum of 45 
minutes/week may represent a more feasible activity goal than the current physical activity guideline of 
150 minutes/week. Success in meeting the MV‐total threshold of 45 minutes/week increased the 
likelihood of functional preservation in high‐functioning persons and functional improvement in those 
with functional limitations, providing an intermediate goal towards achieving the current aerobic 
physical activity guideline. 
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